Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 30718277)

  • 1. PDZK1-interacting protein 1 (PDZK1IP1) traps Smad4 protein and suppresses transforming growth factor-β (TGF-β) signaling.
    Ikeno S; Nakano N; Sano K; Minowa T; Sato W; Akatsu R; Sakata N; Hanagata N; Fujii M; Itoh F; Itoh S
    J Biol Chem; 2019 Mar; 294(13):4966-4980. PubMed ID: 30718277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Phosphoinositide-dependent PDK1 negatively regulates transforming growth factor-beta-induced signaling in a kinase-dependent manner through physical interaction with Smad proteins.
    Seong HA; Jung H; Kim KT; Ha H
    J Biol Chem; 2007 Apr; 282(16):12272-89. PubMed ID: 17327236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C18 ORF1, a novel negative regulator of transforming growth factor-β signaling.
    Nakano N; Maeyama K; Sakata N; Itoh F; Akatsu R; Nakata M; Katsu Y; Ikeno S; Togawa Y; Vo Nguyen TT; Watanabe Y; Kato M; Itoh S
    J Biol Chem; 2014 May; 289(18):12680-92. PubMed ID: 24627487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad7 Protein Interacts with Receptor-regulated Smads (R-Smads) to Inhibit Transforming Growth Factor-β (TGF-β)/Smad Signaling.
    Yan X; Liao H; Cheng M; Shi X; Lin X; Feng XH; Chen YG
    J Biol Chem; 2016 Jan; 291(1):382-92. PubMed ID: 26555259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endofin, a FYVE domain protein, interacts with Smad4 and facilitates transforming growth factor-beta signaling.
    Chen YG; Wang Z; Ma J; Zhang L; Lu Z
    J Biol Chem; 2007 Mar; 282(13):9688-9695. PubMed ID: 17272273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad4-dependent TGF-beta signaling suppresses RON receptor tyrosine kinase-dependent motility and invasion of pancreatic cancer cells.
    Zhao S; Ammanamanchi S; Brattain M; Cao L; Thangasamy A; Wang J; Freeman JW
    J Biol Chem; 2008 Apr; 283(17):11293-301. PubMed ID: 18310076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-362 negatively and positively regulates SMAD4 expression in TGF-β/SMAD signaling to suppress cell migration and invasion.
    Cheng HP; Huang CJ; Tsai ML; Ong HT; Cheong SK; Choo KB; Chiou SH
    Int J Med Sci; 2021; 18(8):1798-1809. PubMed ID: 33746597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimetastatic role of Smad4 signaling in colorectal cancer.
    Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
    Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CTGF mediates Smad-dependent transforming growth factor β signaling to regulate mesenchymal cell proliferation during palate development.
    Parada C; Li J; Iwata J; Suzuki A; Chai Y
    Mol Cell Biol; 2013 Sep; 33(17):3482-93. PubMed ID: 23816882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of functional Schistosoma mansoni Smad4: role in Erk-mediated transforming growth factor beta (TGF-beta) down-regulation.
    Osman A; Niles EG; LoVerde PT
    J Biol Chem; 2004 Feb; 279(8):6474-86. PubMed ID: 14630909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear Respiratory Factor-1, a Novel SMAD4 Binding Protein, Represses TGF-β/SMAD4 Signaling by Functioning as a Transcriptional Cofactor.
    Rajasekaran N; Song K; Lee JH; Wei Y; Erkin ÖC; Lee H; Shin YK
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad4-mediated TGF-beta signaling in tumorigenesis.
    Yang G; Yang X
    Int J Biol Sci; 2010 Jan; 6(1):1-8. PubMed ID: 20087440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling.
    Yu J; Zhang L; Chen A; Xiang G; Wang Y; Wu J; Mitchelson K; Cheng J; Zhou Y
    J Cell Physiol; 2008 May; 215(2):422-33. PubMed ID: 17960585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMAD4 Feedback Activates the Canonical TGF-β Family Signaling Pathways.
    Liu L; Li Q; Yang L; Li Q; Du X
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.
    Kamato D; Burch ML; Piva TJ; Rezaei HB; Rostam MA; Xu S; Zheng W; Little PJ; Osman N
    Cell Signal; 2013 Oct; 25(10):2017-24. PubMed ID: 23770288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis.
    Xue J; Lin X; Chiu WT; Chen YH; Yu G; Liu M; Feng XH; Sawaya R; Medema RH; Hung MC; Huang S
    J Clin Invest; 2014 Feb; 124(2):564-79. PubMed ID: 24382352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.
    Xia W; Lo CM; Poon RYC; Cheung TT; Chan ACY; Chen L; Yang S; Tsao GSW; Wang XQ
    Oncotarget; 2017 Jun; 8(24):38811-38824. PubMed ID: 28415588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.